Service Line:+86-022-82164980
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:[email protected]
Catalog Number | YR1003 |
---|---|
Product Name | Anti-Human C5 Recombinant Antibody(Eculizumab) |
Molecular Name | Eculizumab |
Alias | Anti-C5 Recombinant Antibody, Research Grade Eculizumab |
CAS Number | 219685-50-4 |
Molecular Weight | 148 kDa |
Target | C5[Homo sapiens] |
Isotype | IgG2-G4 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | ELISA, FCM, IP, FuncS, IF, Neut |
Buffer | PBS, pH7.5 |
Background | Eculizumab, sold under the brand name Soliris among others, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and neuromyelitis optica. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |